Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,839 | 0 | 1 | 5,377 | 1 |
| Receivables | N/A | N/A | N/A | 4 | N/A |
| TOTAL | $37,091 | $0 | $1 | $5,472 | $1 |
| Non-Current Assets | |||||
| PPE Net | 35 | N/A | N/A | 49 | N/A |
| Other Non-Current Assets | 45 | 0 | 0 | 45 | 0 |
| TOTAL | $80 | $N/A | $N/A | $94 | $N/A |
| Total Assets | $37,171 | $0 | $1 | $5,566 | $1 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,483 | 17 | 15 | 87 | 7 |
| Accrued Expenses | 145 | N/A | N/A | 108 | N/A |
| TOTAL | $1,628 | $18 | $15 | $213 | $7 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 37 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $37 | $N/A |
| Total Liabilities | $1,628 | $18 | $15 | $250 | $7 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 650 | 206 | 206 | 206 | 206 |
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -43,474 | -88 | -85 | -37,274 | -77 |
| TOTAL | $35,542 | $-18 | $-15 | $5,316 | $-6 |
| Total Liabilities And Equity | $37,171 | $0 | $1 | $5,566 | $1 |